Cell Based Assays in Drug Discovery: Changing the HTS ParadigmTuesday, 12 November 2013 at 11:30 Add to Calendar ▼2013-11-12 11:30:002013-11-12 12:30:00Europe/LondonCell Based Assays in Drug Discovery: Changing the HTS ParadigmScreening Asia in SingaporeSingaporeSELECTBIOenquiries@selectbiosciences.com High content assays (HCA) have successfully evolved over the course of nearly two decades now, enabling us to perform highly complex cellular based screens, sometimes involving primary and/or human embryonic stem cells. With this development and acceptance as a screening platform, came data explosion requiring special logistics typically not associated with screening operations. I will present examples of how these cell based assays have allowed us to screen for modulators of different biologies and therapeutic areas notably not achievable through the classical target based approaches. I will also discuss our technology development effort capitalizing on HCA’s uses during the entire course of discovery. |